Revision history of "Lenvatinib Equals Sorafenib For Unresectable HCC OS"

Jump to navigation Jump to search

Diff selection: Mark the radio boxes of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

  • curprev 12:17, 4 February 2020LeahDefazio57 talk contribs 4,546 bytes +4,546 Created page with "Oncotarget (a primarily oncology-focused, peer-reviewed, open entry, weekly journal) goals to maximise research affect by insightful peer-review; remove borders between specia..."